• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Tumour Biology
    • Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Tumour Biology
    • Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury

    View/Open
    66.pdf (85.81Kb)
    Volume
    28
    Pagination
    799 - 804
    DOI
    10.1111/j.1365-2036.2008.03783.x
    Journal
    ALIMENT PHARM THER
    Issue
    6
    ISSN
    0269-2813
    Metadata
    Show full item record
    Authors
    Marchbank, T; Limdi, JK; Mahmood, A; Elia, G; Playford, RJ
    URI
    https://qmro.qmul.ac.uk/xmlui/handle/123456789/178
    Collections
    • Centre for Tumour Biology [314]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.